These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9346585)

  • 1. Hepatic allograft rejection is associated with increased levels of soluble intercellular adhesion molecule-1.
    Ninova D; Krom RA; Wiesner RH
    Liver Transpl Surg; 1995 Sep; 1(5):290-5. PubMed ID: 9346585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different time course of circulating adhesion molecules and hyaluran during hepatic allograft rejection.
    Fábrega E; Castro B; Crespo J; de la Peña J; Gómez-Fleitas M; García-Unzueta MT; Amado JA; Pons-Romero F
    Transplantation; 2000 Feb; 69(4):569-73. PubMed ID: 10708113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adhesion molecule behavior during rejection and infection episodes after heart transplantation.
    Weigel G; Grimm M; Griesmacher A; Seebacher G; Sichrovsky T; Wolner E; Laufer G; Müller MM
    Clin Chem Lab Med; 2000 May; 38(5):403-8. PubMed ID: 10952222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble intercellular adhesion molecule-1 (sICAM-1) after kidney transplantation: the origin and role of urinary sICAM-1?
    Teppo AM; von Willebrand E; Honkanen E; Ahonen J; Grönhagen-Riska C
    Transplantation; 2001 Apr; 71(8):1113-9. PubMed ID: 11374412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute rejection before cytomegalovirus infection enhances von Willebrand factor and soluble VCAM-1 in blood.
    Kas-Deelen AM; Harmsen MC; De Maar EF; Oost-Kort WW; Tervaert JW; Van Der Meer J; Van Son WJ; The TH
    Kidney Int; 2000 Dec; 58(6):2533-42. PubMed ID: 11115088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble adhesion molecules in renal transplantation.
    Bricio T; Rivera M; Molina A; Martin A; Burgos J; Mampaso F
    Ren Fail; 1996 Jan; 18(1):75-83. PubMed ID: 8820503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble T lymphocyte markers in the diagnosis of cellular rejection and cytomegalovirus hepatitis in liver transplant recipients.
    Ninova DI; Wiesner RH; Gores GJ; Harrison JM; Krom RA; Homburger HA
    J Hepatol; 1994 Dec; 21(6):1080-5. PubMed ID: 7699231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of immunohistopathologic methods for the diagnosis of cytomegalovirus hepatitis in human liver allograft biopsy specimens.
    Barkholt LM; Ehrnst A; Veress B
    Scand J Gastroenterol; 1994 Jun; 29(6):553-60. PubMed ID: 8079116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of serum-soluble intercellular adhesion molecule-1 for the noninvasive risk assessment of transplant coronary artery disease, posttransplant ischemic events, and cardiac graft failure.
    Labarrere CA; Nelson DR; Miller SJ; Nieto JM; Conner JA; Pitts DE; Kirlin PC; Halbrook HG
    Circulation; 2000 Sep; 102(13):1549-55. PubMed ID: 11004146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating soluble vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in immunocompetent and renal transplant patients: correlation with cytomegalovirus disease and renal function.
    Eriksson BM; Sjölin J; Claesson K; Wirgart BZ; Grillner L; Tötterman TH
    Scand J Infect Dis; 2001; 33(5):350-4. PubMed ID: 11440220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICAM-1 induction on hepatocytes as a marker for immune activation of acute liver allograft rejection.
    Lautenschlager IT; Höckerstedt KA
    Transplantation; 1993 Dec; 56(6):1495-9. PubMed ID: 7904090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of increased levels of circulating intercellular adhesion molecule 1 after heart transplantation to rejection: human leukocyte antigen mismatch and survival.
    Ballantyne CM; Mainolfi EA; Young JB; Windsor NT; Cocanougher B; Lawrence EC; Pollack MS; Entman ML; Rothlein R
    J Heart Lung Transplant; 1994; 13(4):597-603. PubMed ID: 7947875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum levels of circulating intercellular adhesion molecule 1 predict the risk of graft rejection after bone marrow transplantation for thalassemia.
    Centis F; Delfini C; Annibali M; Galimberti M; Agostinelli F; Nicolini G; Lucarelli G
    Bone Marrow Transplant; 1997 Jul; 20(2):125-8. PubMed ID: 9244415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating ICAM-1, E-selectin, IL-2 receptor, and HLA class I in human small bowel, liver, and small bowel-plus-liver transplant recipients.
    Satoh S; Thomson AW; Nakamura K; Warty V; Todo S
    Transplantation; 1995 Sep; 60(6):558-62. PubMed ID: 7570951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intercellular adhesion molecule 1 (ICAM-1) induction on hepatocytes is an early marker of acute liver allograft rejection.
    Lautenschlager I; Höckerstedt K; Häyry P
    Transpl Int; 1992; 5 Suppl 1():S283-5. PubMed ID: 14621802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of circulating adhesion molecules in assessing cardiac allograft vasculopathy.
    Wu YW; Lee CM; Lee YT; Wang SS; Huang PJ
    J Heart Lung Transplant; 2003 Nov; 22(11):1284-7. PubMed ID: 14585391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum intercellular adhesion molecule-I in children with chronic liver disease: relationship to disease activity.
    Abdalla A; Sheesha AA; Shokeir M; el-Agrody O; el-Regal ME; Abdel-Khalik MK; Freeman K; Boneberg A; A-Kader HH
    Dig Dis Sci; 2002 Jun; 47(6):1206-8. PubMed ID: 12064792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of cytomegalovirus hepatitis in liver transplant patients.
    Bronsther O; Makowka L; Jaffe R; Demetris AJ; Breinig MK; Ho M; Esquivel CO; Gordon RD; Iwatsuki S; Tzakis A
    J Med Virol; 1988 Apr; 24(4):423-34. PubMed ID: 2835433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal allograft rejection: the temporal relationship and predictive value of plasma TNF (alpha and beta), IFN-gamma and soluble ICAM-1.
    Kutukculer N; Shenton BK; Clark K; Rigg KM; Forsythe JL; Kirby JA; Proud G; Taylor RM
    Transpl Int; 1995; 8(1):45-50. PubMed ID: 7888051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential patterns of circulating intercellular adhesion molecule-1 (cICAM-1) and vascular cell adhesion molecule-1 (cVCAM-1) during liver allograft rejection.
    Lang T; Krams SM; Villanueva JC; Cox K; So S; Martinez OM
    Transplantation; 1995 Feb; 59(4):584-9. PubMed ID: 7533349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.